CVR: 38189174
Not available
Net result: EUR 0
No owners listed
CVR · view ownership and management
Director role ended: Kim Hersland
CVR · 24/03/2024
View the full event history
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016 and dissolved in 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a net result of EUR 0 compared with EUR 0 the year before. Equity in the 2023 report amounted to EUR 27,000.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | - | 0 EUR | 27 t. EUR | 27 t. EUR | 0 | |
| 202201/01/2022 – 31/12/2022 | - | 0 EUR | 27 t. EUR | 27 t. EUR | - | |
| 202101/01/2021 – 31/12/2021 | - | 0 EUR | 7 t. EUR | 7 t. EUR | - | |
| 202001/01/2020 – 31/12/2020 | - | 0 EUR | 7 t. EUR | 7 t. EUR | - | |
| 201901/01/2019 – 31/12/2019 | - | 0 EUR | 7 t. EUR | 7 t. EUR | - | |
| 201801/01/2018 – 31/12/2018 | - | 0 EUR | 7 t. EUR | 7 t. EUR | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. GemCap Biotech ApS is registered in the Danish CVR register with the status Dissolved and ceased on 24 March 2024.
GemCap Biotech ApS was founded on 17 November 2016.
GemCap Biotech ApS was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n. (industry code 649900).
GemCap Biotech ApS was located at c/o GemCap ApS, Lyngby Hovedgade 10C, 2800 Kongens Lyngby.
The CVR number of GemCap Biotech ApS is 38189174.
GemCap Biotech ApS has published its annual report for 2023. The net result was DKK 0.
As of March 24, 2024, Kim Hersland has left the board of directors of GemCap Biotech ApS.
As of March 24, 2024, Kim Hersland has stepped down as adm. dir. of GemCap Biotech ApS.
As of March 24, 2024, Christian Frederik Harboe Wissum has stepped down as chairman of GemCap Biotech ApS.
GemCap Biotech ApS was dissolved on March 24, 2024.
GemCap Biotech ApS has published its annual report for 2022. The net result was DKK 0.
GemCap Biotech ApS has published its annual report for 2021. The net result was DKK 0.
GemCap Biotech ApS has published its annual report for 2020. The net result was DKK 0.
GemCap Biotech ApS has published its annual report for 2019. The net result was DKK 0.
As of May 28, 2020, Werner Schmidt has left the board of directors of GemCap Biotech ApS.
As of January 27, 2020, Werner Schmidt has joined the board of directors of GemCap Biotech ApS.
As of January 27, 2020, Werner Ernst Spiegler has left the board of directors of GemCap Biotech ApS.
GemCap Biotech ApS has published its annual report for 2018. The net result was DKK 0.
GemCap Biotech ApS has published its interim report for the period November 17, 2016 – December 31, 2017.
As of November 17, 2016, Kim Hersland has joined the board of directors of GemCap Biotech ApS.
As of November 17, 2016, Werner Ernst Spiegler has joined the board of directors of GemCap Biotech ApS.
As of November 17, 2016, Kim Hersland is registered as adm. dir. of GemCap Biotech ApS.
As of November 17, 2016, Christian Frederik Harboe Wissum is registered as chairman of GemCap Biotech ApS.
GemCap Biotech ApS was founded on November 17, 2016.
Companies in the same industry and area
CVR 40267875
CVR 10063167
CVR 16672289
CVR 10473802
CVR 46518098
